Drug Profile
Middle-East respiratory syndrome coronavirus vaccine - Organic Vaccines
Alternative Names: MERS-CoV vaccine - Organic VaccinesLatest Information Update: 24 Jul 2023
Price :
$50
*
At a glance
- Originator National Institutes of Health (USA); Organic Vaccines
- Developer Organic Vaccines
- Class COVID-19 vaccines; Monoclonal antibodies; Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Middle East respiratory syndrome coronavirus
Most Recent Events
- 24 Jul 2023 Discontinued - Preclinical for Middle East respiratory syndrome coronavirus in France (Parenteral)
- 24 Jul 2023 Phase-I/II clinical trials in Middle East respiratory syndrome coronavirus in Saudi Arabia (Parenteral)
- 28 Apr 2019 No recent reports of development identified for clinical-Phase-Unknown development in Middle-East-respiratory-syndrome-coronavirus in Saudi Arabia (Parenteral)